Market revenue in 2023 | USD 4,318.4 million |
Market revenue in 2030 | USD 7,013.1 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Software |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
Instruments was the largest segment with a revenue share of 35.4% in 2023. Horizon Databook has segmented the Global flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
Flow cytometry is commonly used for the diagnosis of cancer and immunodeficiency. Increasing prevalence of these diseases is one of the factors anticipated to drive the market over the forecast period. According to WHO data, around 10 million cancer deaths were recorded in 2021 globally.
Flow cytometry is a significant tool in listing and characterizing immune cells, and it is also helpful in recognizing and validating underlying genetic defects. The technique is also used to observe and monitor the immune response of patients after stem cell transplantation, and hence, organ transplantation plays an important role in boosting the market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account